Definium Therapeutics
DFTX
28.34
-1.14
-3.87%
Definium Therapeutics
US · DFTX
#2132 by market cap
Listed 1970
28.34
-1.14
-3.87%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Quant vs Street three independent views, side by side
StockVane factor grade
B-
Momentum strategy signal
Sell
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 14 analysts
Buy
Avg price target 74.31 +162.2%
Price target rangecurrent 28.34
Low55.00
Avg74.31
High91.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-12 | JonesTrading | -- | Buy | 90.00 |
| 2026-11-12 | Maxim Group | -- | Buy | 55.00 |
| 2026-11-11 | Wells Fargo | -- | Buy | 72.00 |
| 2026-11-10 | CCORF | -- | Buy | 78.00 |
| 2026-11-10 | Piper Sandler | -- | Buy | 75.00 |
| 2026-11-10 | Needham | -- | Buy | 66.00 |
| 2026-11-10 | Oppenheimer | -- | Buy | 75.00 |
| 2026-11-09 | BofA Securities | -- | Buy | 91.00 |
| 2026-11-09 | H.C. Wainwright | -- | Buy | 70.00 |
| 2026-11-09 | RBC Capital | -- | Buy | 70.00 |
| 2026-11-09 | J.P. Morgan | -- | Buy | -- |
| 2026-10-19 | RBC Capital | -- | Buy | 66.00 |
| 2026-10-09 | J.P. Morgan | -- | Buy | 84.00 |
| 2026-10-07 | BofA Securities | -- | Buy | 91.00 |
| 2026-09-19 | LifeSci Capital | -- | Buy | 78.00 |
| 2026-09-15 | CCORF | -- | Buy | 78.00 |
| 2026-09-15 | JonesTrading | -- | Buy | 90.00 |
| 2026-09-15 | Maxim Group | -- | Buy | 55.00 |
| 2026-09-15 | Baird | -- | Buy | 79.00 |
| 2026-09-15 | Stifel | -- | Buy | 67.00 |
| 2026-09-15 | H.C. Wainwright | -- | Buy | 70.00 |
| 2026-09-14 | LifeSci Capital | -- | Buy | 78.00 |
| 2026-09-14 | BofA Securities | -- | Buy | 91.00 |
| 2026-09-14 | Needham | -- | Buy | 66.00 |
| 2026-09-14 | H.C. Wainwright | -- | Buy | 70.00 |
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-09 | After close | ±12.85% | -2.12% (in line) |
| 2026/Q2 | 2026-08-06 | After close | ±23.43% | +0.00% (in line) |
| 2026/Q1 | 2026-05-07 | After close | ±10.00% | -4.96% (in line) |
| 2025/Q4 | 2026-02-26 | After close | ±12.30% | +0.93% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 20:02:39 · For reference only, not investment advice and not tailored to your situation.
Definium Therapeutics discussion 0 comments